| 摘要 |
NZ 586701 Disclosed is an isolated full length antibody comprising an antibody combining site that targets a tumour antigen, wherein said antibody is operably-linked to at least one modular recognition domain (MRD) between 2 and 60 amino acids in length which targets Ang-2. The disclosed antibody is used in the treatment of cancer and tumours. |
